CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Revenues	$ 994,265	$ 338,863
Cost of revenue	1,226,321	1,224,652
Gross Loss	(232,056)	(885,789)
Operating expenses:
Selling and marketing	713,972	884,440
Research and development	343,712	375,817
General and administrative	2,568,227	4,633,702
Impairment of related party non-marketable securities	50,000	0
Amortization and depreciation	570,247	534,220
Total operating expenses	4,246,158	6,428,179
Operating loss	(4,478,214)	(7,313,968)
Other income (expense):
Unrealized gain (loss) on derivative liabilities	(2,758,488)	187,932
Unrealized loss on marketable securities	(2,400)	(10,200)
Loss on settlement of debt	(1,664,281)	0
Other income	750	3,814
Interest expense	(675,997)	(76,723)
Total other income (expense)	(5,100,416)	104,823
Net loss	(9,578,630)	(7,209,145)
Deemed dividend on Series A Convertible preferred stock	0	(594,641)
Dividend on Series A Convertible preferred stock	(80,000)	(58,733)
Net loss available to common stockholders	$ (9,658,630)	$ (7,862,519)
Net loss per common share-basic and diluted	$ (0.10)	$ (0.10)
Weighted average common shares outstanding-basic and diluted	98,905,556	80,445,509